Liquid chromatographic determination of sitagliptin either alone or in ternary mixture with metformin and sitagliptin degradation product

Clarke's Analysis of Drugs and Poisons

Akira Ishii · Legal Medicine · 2004 · 774 citations

Pharmacy, Pharmacy Practice, Pharmaceutical Toxicology +4

Pharmacokinetics and Pharmacodynamic Effects of the Oral DPP‐4 Inhibitor Sitagliptin in Middle‐Aged Obese Subjects

Gary Herman, Arthur Bergman, Fang Liu et al. · The Journal of Clinical Pharmacology · 2006 · 185 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

First Generation Process for the Preparation of the DPP-IV Inhibitor Sitagliptin

Karl B. Hansen, Jaume Balsells, Spencer D. Dreher et al. · Organic Process Research & Development · 2005 · 162 citations

Pharmacy, Medicinal Chemistry, Pharmacology +10

Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 mice fed on a very high-fat diet

Vanessa Souza‐Mello, Bianca Martins Gregório, Fernando S. Cardoso-de-Lemos et al. · Clinical Science · 2010 · 135 citations

Medicine, Endocrinology, Pharmacology +17

HPLC-UV determination of metformin in human plasma for application in pharmacokinetics and bioequivalence studies

Valentina Porta, Simone Grigoleto Schramm, Eunice Kazue Kano et al. · Journal of Pharmaceutical and Biomedical Analysis · 2007 · 123 citations

Pharmacy, Pharmacokinetics, Pharmacology +14